<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-10-01" modified="2020-10-07" version="242">
<accession>Q00653</accession>
<accession>A8K9D9</accession>
<accession>D3DR83</accession>
<accession>Q04860</accession>
<accession>Q9BU75</accession>
<accession>Q9H471</accession>
<accession>Q9H472</accession>
<name>NFKB2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nuclear factor NF-kappa-B p100 subunit</fullName>
</recommendedName>
<alternativeName>
<fullName>DNA-binding factor KBF2</fullName>
</alternativeName>
<alternativeName>
<fullName>H2TF1</fullName>
</alternativeName>
<alternativeName>
<fullName>Lymphocyte translocation chromosome 10 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Oncogene Lyt-10</fullName>
<shortName>Lyt10</shortName>
</alternativeName>
<component>
<recommendedName>
<fullName>Nuclear factor NF-kappa-B p52 subunit</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">NFKB2</name>
<name type="synonym">LYT10</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Nature" volume="352" first="733" last="736">
<title>Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.</title>
<authorList>
<person name="Schmid R.M."/>
<person name="Perkins N.D."/>
<person name="Duckett C.S."/>
<person name="Andrews P.C."/>
<person name="Nabel G.J."/>
</authorList>
<dbReference type="PubMed" id="1876189"/>
<dbReference type="DOI" id="10.1038/352733a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Leukemia</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Mol. Cell. Biol." volume="12" first="685" last="695">
<title>A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.</title>
<authorList>
<person name="Bours V."/>
<person name="Burd P.R."/>
<person name="Brown K."/>
<person name="Villalobos J."/>
<person name="Park S."/>
<person name="Ryseck R.P."/>
<person name="Bravo R."/>
<person name="Kelly K."/>
<person name="Siebenlist U."/>
</authorList>
<dbReference type="PubMed" id="1531086"/>
<dbReference type="DOI" id="10.1128/mcb.12.2.685"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="2335" last="2344">
<title>Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells.</title>
<authorList>
<person name="Thakur S."/>
<person name="Lin H.C."/>
<person name="Tseng W.T."/>
<person name="Kumar S."/>
<person name="Bravo R."/>
<person name="Foss F."/>
<person name="Gelinas C."/>
<person name="Rabson A.B."/>
</authorList>
<dbReference type="PubMed" id="8036016"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHROMOSOMAL TRANSLOCATION</scope>
<scope>P80HT GENERATION</scope>
</reference>
<reference key="4">
<citation type="submission" date="2006-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Rabson A.B."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="5">
<citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2004-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LYS-14; ARG-351 AND ARG-452</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="Mol. Cell. Biol." volume="14" first="7695" last="7703">
<title>Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation.</title>
<authorList>
<person name="Liptay S."/>
<person name="Schmid R.M."/>
<person name="Nabel E.G."/>
<person name="Nabel G.J."/>
</authorList>
<dbReference type="PubMed" id="7969113"/>
<dbReference type="DOI" id="10.1128/mcb.14.12.7695"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-220</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="18882" last="18890">
<title>Purification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 gene.</title>
<authorList>
<person name="Potter D.A."/>
<person name="Larson C.J."/>
<person name="Eckes P."/>
<person name="Schmid R.M."/>
<person name="Nabel G.J."/>
<person name="Verdine G.L."/>
<person name="Sharp P.A."/>
</authorList>
<dbReference type="PubMed" id="8360178"/>
</citation>
<scope>PROTEIN SEQUENCE OF 459-470; 580-597 AND 636-647 (ISOFORM 1)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1993" name="Cell" volume="72" first="729" last="739">
<title>The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.</title>
<authorList>
<person name="Bours V."/>
<person name="Franzoso G."/>
<person name="Azarenko V."/>
<person name="Park S."/>
<person name="Kanno T."/>
<person name="Brown K."/>
<person name="Siebenlist U."/>
</authorList>
<dbReference type="PubMed" id="8453667"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90401-b"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH BCL3</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="4608" last="4616">
<title>Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity.</title>
<authorList>
<person name="Dobrzanski P."/>
<person name="Ryseck R.P."/>
<person name="Bravo R."/>
</authorList>
<dbReference type="PubMed" id="7925301"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1994.tb06782.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE NF-KAPPA-B RELB-P52 COMPLEX</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="1487" last="1492">
<title>Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.</title>
<authorList>
<person name="Beg A.A."/>
<person name="Baldwin A.S. Jr."/>
</authorList>
<dbReference type="PubMed" id="8152812"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P52-C-REL COMPLEX</scope>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-P52 COMPLEX</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="6184" last="6190">
<title>A new member of the IkappaB protein family, IkappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.</title>
<authorList>
<person name="Li Z."/>
<person name="Nabel G.J."/>
</authorList>
<dbReference type="PubMed" id="9315679"/>
<dbReference type="DOI" id="10.1128/mcb.17.10.6184"/>
</citation>
<scope>INTERACTION WITH NFKBIE</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="6201" last="6208">
<title>The generation of nfkb2 p52: mechanism and efficiency.</title>
<authorList>
<person name="Heusch M."/>
<person name="Lin L."/>
<person name="Geleziunas R."/>
<person name="Greene W.C."/>
</authorList>
<dbReference type="PubMed" id="10597218"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203022"/>
</citation>
<scope>COTRANSLATIONAL FOLDING/PROCESSING OF P100</scope>
<scope>GENERATION OF P52/P100</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="6363" last="6371">
<title>Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences.</title>
<authorList>
<person name="Betts J.C."/>
<person name="Nabel G.J."/>
</authorList>
<dbReference type="PubMed" id="8887665"/>
<dbReference type="DOI" id="10.1128/mcb.16.11.6363"/>
</citation>
<scope>PHOSPHORYLATION AT SER-713; SER-715 AND SER-717</scope>
<scope>MUTAGENESIS</scope>
<scope>DIMERIZATION</scope>
<scope>PROTEOLYTIC PROCESSING OF P100</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="401" last="409">
<title>NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.</title>
<authorList>
<person name="Xiao G."/>
<person name="Harhaj E.W."/>
<person name="Sun S.-C."/>
</authorList>
<dbReference type="PubMed" id="11239468"/>
<dbReference type="DOI" id="10.1016/s1097-2765(01)00187-3"/>
</citation>
<scope>PHOSPHORYLATION AT SER-866 AND SER-870</scope>
<scope>MUTAGENESIS OF SER-866 AND SER-870</scope>
<scope>PROTEOLYTIC PROCESSING OF P100</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1991" name="Cell" volume="67" first="1075" last="1087">
<title>B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.</title>
<authorList>
<person name="Neri A."/>
<person name="Chang C.C."/>
<person name="Lombardi L."/>
<person name="Salina M."/>
<person name="Corradini P."/>
<person name="Maiolo A.T."/>
<person name="Chaganti R.S."/>
<person name="Dalla-Favera R."/>
</authorList>
<dbReference type="PubMed" id="1760839"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90285-7"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH IGHA1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1994" name="Blood" volume="84" first="3850" last="3860">
<title>Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.</title>
<authorList>
<person name="Migliazza A."/>
<person name="Lombardi L."/>
<person name="Rocchi M."/>
<person name="Trecca D."/>
<person name="Chang C.-C."/>
<person name="Antonacci R."/>
<person name="Fracchiolla N.S."/>
<person name="Ciana P."/>
<person name="Maiolo A.T."/>
<person name="Neri A."/>
</authorList>
<dbReference type="PubMed" id="7949142"/>
</citation>
<scope>CHROMOSOMAL ABERRATIONS</scope>
<scope>GENERATION OF LB40 AND EB308</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1995" name="Nucleic Acids Res." volume="23" first="2328" last="2336">
<title>Structural and functional characterization of the promoter regions of the NFKB2 gene.</title>
<authorList>
<person name="Lombardi L."/>
<person name="Ciana P."/>
<person name="Cappellini C."/>
<person name="Trecca D."/>
<person name="Guerrini L."/>
<person name="Migliazza A."/>
<person name="Maiolo A.T."/>
<person name="Neri A."/>
</authorList>
<dbReference type="PubMed" id="7541912"/>
<dbReference type="DOI" id="10.1093/nar/23.12.2328"/>
</citation>
<scope>CHARACTERIZATION OF THE TWO PROMOTER REGIONS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="4917" last="4925">
<title>The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation.</title>
<authorList>
<person name="Heppner C."/>
<person name="Bilimoria K.Y."/>
<person name="Agarwal S.K."/>
<person name="Kester M."/>
<person name="Whitty L.J."/>
<person name="Guru S.C."/>
<person name="Chandrasekharappa S.C."/>
<person name="Collins F.S."/>
<person name="Spiegel A.M."/>
<person name="Marx S.J."/>
<person name="Burns A.L."/>
</authorList>
<dbReference type="PubMed" id="11526476"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204529"/>
</citation>
<scope>INTERACTION WITH MEN1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="2540" last="2547">
<title>Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase.</title>
<authorList>
<person name="Amir R.E."/>
<person name="Haecker H."/>
<person name="Karin M."/>
<person name="Ciechanover A."/>
</authorList>
<dbReference type="PubMed" id="14676825"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207366"/>
</citation>
<scope>UBIQUITINATION AT LYS-855</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="2689" last="2694">
<title>IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.</title>
<authorList>
<person name="Song Y.J."/>
<person name="Jen K.Y."/>
<person name="Soni V."/>
<person name="Kieff E."/>
<person name="Cahir-McFarland E."/>
</authorList>
<dbReference type="PubMed" id="16477006"/>
<dbReference type="DOI" id="10.1073/pnas.0511096103"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-P52 COMPLEX</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-429</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-161 AND SER-812</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="7078" last="7090">
<title>Structure of the human NF-kappaB p52 homodimer-DNA complex at 2.1-A resolution.</title>
<authorList>
<person name="Cramer P."/>
<person name="Larson C.J."/>
<person name="Verdine G.L."/>
<person name="Mueller C.W."/>
</authorList>
<dbReference type="PubMed" id="9384586"/>
<dbReference type="DOI" id="10.1093/emboj/16.23.7078"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 37-327</scope>
</reference>
<reference key="32">
<citation type="submission" date="2006-12" db="PDB data bank">
<title>Solution structure of the death domain of nuclear factor NF-kappa-B p100.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 764-859</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="93" first="812" last="824">
<title>Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency.</title>
<authorList>
<person name="Chen K."/>
<person name="Coonrod E.M."/>
<person name="Kumanovics A."/>
<person name="Franks Z.F."/>
<person name="Durtschi J.D."/>
<person name="Margraf R.L."/>
<person name="Wu W."/>
<person name="Heikal N.M."/>
<person name="Augustine N.H."/>
<person name="Ridge P.G."/>
<person name="Hill H.R."/>
<person name="Jorde L.B."/>
<person name="Weyrich A.S."/>
<person name="Zimmerman G.A."/>
<person name="Gundlapalli A.V."/>
<person name="Bohnsack J.F."/>
<person name="Voelkerding K.V."/>
</authorList>
<dbReference type="PubMed" id="24140114"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2013.09.009"/>
</citation>
<scope>INVOLVEMENT IN CVID10</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="BMC Med. Genet." volume="15" first="139" last="139">
<title>Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies.</title>
<authorList>
<person name="Brue T."/>
<person name="Quentien M.H."/>
<person name="Khetchoumian K."/>
<person name="Bensa M."/>
<person name="Capo-Chichi J.M."/>
<person name="Delemer B."/>
<person name="Balsalobre A."/>
<person name="Nassif C."/>
<person name="Papadimitriou D.T."/>
<person name="Pagnier A."/>
<person name="Hasselmann C."/>
<person name="Patry L."/>
<person name="Schwartzentruber J."/>
<person name="Souchon P.F."/>
<person name="Takayasu S."/>
<person name="Enjalbert A."/>
<person name="Van Vliet G."/>
<person name="Majewski J."/>
<person name="Drouin J."/>
<person name="Samuels M.E."/>
</authorList>
<dbReference type="PubMed" id="25524009"/>
<dbReference type="DOI" id="10.1186/s12881-014-0139-9"/>
</citation>
<scope>VARIANTS CVID10 GLY-865 AND VAL-867</scope>
</reference>
<comment type="function">
<text evidence="16">NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer.</text>
</comment>
<comment type="subunit">
<text evidence="11 13 16 17 18 20">Component of the NF-kappa-B RelB-p52 complex. Homodimer; component of the NF-kappa-B p52-p52 complex. Component of the NF-kappa-B p65-p52 complex. Component of the NF-kappa-B p52-c-Rel complex. NFKB2/p52 interacts with NFKBIE. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Directly interacts with MEN1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307326">
<id>Q00653</id>
</interactant>
<interactant intactId="EBI-354900">
<id>P41279</id>
<label>MAP3K8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307326">
<id>Q00653</id>
</interactant>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307326">
<id>Q00653</id>
</interactant>
<interactant intactId="EBI-307386">
<id>P25963</id>
<label>NFKBIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307326">
<id>Q00653</id>
</interactant>
<interactant intactId="EBI-307352">
<id>Q04864</id>
<label>REL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307326">
<id>Q00653</id>
</interactant>
<interactant intactId="EBI-357837">
<id>Q01201</id>
<label>RELB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307326">
<id>Q00653</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9869360">
<id>PRO_0000030322</id>
</interactant>
<interactant intactId="EBI-9869387">
<id>O00255-2</id>
<label>MEN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q00653-1</id>
<name>1</name>
<name>p100</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q00653-3</id>
<name>3</name>
<name>p49</name>
<sequence type="described" ref="VSP_040082 VSP_040083"/>
</isoform>
<isoform>
<id>Q00653-4</id>
<name>4</name>
<sequence type="described" ref="VSP_040084"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="7">The C-terminus of p100 might be involved in cytoplasmic retention, inhibition of DNA-binding by p52 homodimers, and/or transcription activation.</text>
</comment>
<comment type="domain">
<text>The glycine-rich region (GRR) appears to be a critical element in the generation of p52.</text>
</comment>
<comment type="PTM">
<text>While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p52 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.</text>
</comment>
<comment type="PTM">
<text evidence="10 12 19">Subsequent to MAP3K14-dependent serine phosphorylation, p100 polyubiquitination occurs then triggering its proteasome-dependent processing.</text>
</comment>
<comment type="PTM">
<text>Constitutive processing is tightly suppressed by its C-terminal processing inhibitory domain, named PID, which contains the death domain.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving NFKB2 is found in a case of B-cell non Hodgkin lymphoma (B-NHL). Translocation t(10;14)(q24;q32) with IGHA1. The resulting oncogene is also called Lyt-10C alpha variant.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving NFKB2 is found in a cutaneous T-cell leukemia (C-TCL) cell line. This rearrangement produces the p80HT gene which codes for a truncated 80 kDa protein (p80HT).</text>
</comment>
<comment type="disease">
<text>In B-cell leukemia (B-CLL) cell line, LB40 and EB308, can be found after heterogeneous chromosomal aberrations, such as internal deletions.</text>
</comment>
<comment type="disease" evidence="14 15">
<disease id="DI-03979">
<name>Immunodeficiency, common variable, 10</name>
<acronym>CVID10</acronym>
<description>A primary immunodeficiency characterized by childhood-onset of recurrent infections, hypogammaglobulinemia, and decreased numbers of memory and marginal zone B-cells. Some patients may develop autoimmune features and have circulating autoantibodies. An unusual feature is central adrenal insufficiency.</description>
<dbReference type="MIM" id="615577"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="26">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="CAA43715" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="26">
<molecule>Isoform 3</molecule>
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="CAA43716" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NFKB2ID362.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/nfkb2/"/>
</comment>
<dbReference type="EMBL" id="X61498">
<property type="protein sequence ID" value="CAA43715.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X61499">
<property type="protein sequence ID" value="CAA43716.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S76638">
<property type="protein sequence ID" value="AAB21124.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U09609">
<property type="protein sequence ID" value="AAA21462.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT009769">
<property type="protein sequence ID" value="AAP88771.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292654">
<property type="protein sequence ID" value="BAF85343.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY865619">
<property type="protein sequence ID" value="AAW56071.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121928">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49700.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49701.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49702.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49704.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49706.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002844">
<property type="protein sequence ID" value="AAH02844.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U20816">
<property type="protein sequence ID" value="AAA68171.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41564.1">
<molecule id="Q00653-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41565.1">
<molecule id="Q00653-4"/>
</dbReference>
<dbReference type="PIR" id="A42024">
<property type="entry name" value="A42024"/>
</dbReference>
<dbReference type="PIR" id="A57034">
<property type="entry name" value="A57034"/>
</dbReference>
<dbReference type="PIR" id="I38609">
<property type="entry name" value="I38609"/>
</dbReference>
<dbReference type="PIR" id="S17233">
<property type="entry name" value="S17233"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001070962.1">
<molecule id="Q00653-1"/>
<property type="nucleotide sequence ID" value="NM_001077494.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001248332.1">
<molecule id="Q00653-4"/>
<property type="nucleotide sequence ID" value="NM_001261403.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001275653.1">
<molecule id="Q00653-4"/>
<property type="nucleotide sequence ID" value="NM_001288724.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001309863.1">
<molecule id="Q00653-1"/>
<property type="nucleotide sequence ID" value="NM_001322934.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001309864.1">
<property type="nucleotide sequence ID" value="NM_001322935.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002493.3">
<molecule id="Q00653-4"/>
<property type="nucleotide sequence ID" value="NM_002502.5"/>
</dbReference>
<dbReference type="PDB" id="1A3Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=37-327"/>
</dbReference>
<dbReference type="PDB" id="2D96">
<property type="method" value="NMR"/>
<property type="chains" value="A=766-859"/>
</dbReference>
<dbReference type="PDB" id="3DO7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="B=37-329"/>
</dbReference>
<dbReference type="PDB" id="4OT9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.35"/>
<property type="chains" value="A=407-765"/>
</dbReference>
<dbReference type="PDB" id="5ZMC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A=35-329"/>
</dbReference>
<dbReference type="PDBsum" id="1A3Q"/>
<dbReference type="PDBsum" id="2D96"/>
<dbReference type="PDBsum" id="3DO7"/>
<dbReference type="PDBsum" id="4OT9"/>
<dbReference type="PDBsum" id="5ZMC"/>
<dbReference type="SMR" id="Q00653"/>
<dbReference type="BioGRID" id="110858">
<property type="interactions" value="69"/>
</dbReference>
<dbReference type="CORUM" id="Q00653"/>
<dbReference type="DIP" id="DIP-24239N"/>
<dbReference type="DIP" id="DIP-27535N"/>
<dbReference type="IntAct" id="Q00653">
<property type="interactions" value="45"/>
</dbReference>
<dbReference type="MINT" id="Q00653"/>
<dbReference type="STRING" id="9606.ENSP00000358983"/>
<dbReference type="ChEMBL" id="CHEMBL3003"/>
<dbReference type="DrugBank" id="DB05767">
<property type="generic name" value="Andrographolide"/>
</dbReference>
<dbReference type="DrugBank" id="DB05487">
<property type="generic name" value="Custirsen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00843">
<property type="generic name" value="Donepezil"/>
</dbReference>
<dbReference type="DrugBank" id="DB13961">
<property type="generic name" value="Fish oil"/>
</dbReference>
<dbReference type="DrugBank" id="DB01296">
<property type="generic name" value="Glucosamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB13751">
<property type="generic name" value="Glycyrrhizic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB05212">
<property type="generic name" value="HE3286"/>
</dbReference>
<dbReference type="DrugBank" id="DB05559">
<property type="generic name" value="NF-kappaB Decoy"/>
</dbReference>
<dbReference type="DrugBank" id="DB05464">
<property type="generic name" value="NOX-700"/>
</dbReference>
<dbReference type="DrugBank" id="DB05451">
<property type="generic name" value="P54"/>
</dbReference>
<dbReference type="DrugBank" id="DB14059">
<property type="generic name" value="SC-236"/>
</dbReference>
<dbReference type="DrugBank" id="DB05471">
<property type="generic name" value="SGN-30"/>
</dbReference>
<dbReference type="DrugCentral" id="Q00653"/>
<dbReference type="CarbonylDB" id="Q00653"/>
<dbReference type="iPTMnet" id="Q00653"/>
<dbReference type="PhosphoSitePlus" id="Q00653"/>
<dbReference type="SwissPalm" id="Q00653"/>
<dbReference type="BioMuta" id="NFKB2"/>
<dbReference type="DMDM" id="116242678"/>
<dbReference type="CPTAC" id="CPTAC-721"/>
<dbReference type="EPD" id="Q00653"/>
<dbReference type="jPOST" id="Q00653"/>
<dbReference type="MassIVE" id="Q00653"/>
<dbReference type="MaxQB" id="Q00653"/>
<dbReference type="PaxDb" id="Q00653"/>
<dbReference type="PeptideAtlas" id="Q00653"/>
<dbReference type="PRIDE" id="Q00653"/>
<dbReference type="ProteomicsDB" id="57866">
<molecule id="Q00653-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57867">
<molecule id="Q00653-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57868">
<molecule id="Q00653-4"/>
</dbReference>
<dbReference type="ABCD" id="Q00653">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="1322">
<property type="antibodies" value="953 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="Q00653">
<property type="antibodies" value="1 antibody"/>
</dbReference>
<dbReference type="DNASU" id="4791"/>
<dbReference type="Ensembl" id="ENST00000189444">
<molecule id="Q00653-4"/>
<property type="protein sequence ID" value="ENSP00000189444"/>
<property type="gene ID" value="ENSG00000077150"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369966">
<molecule id="Q00653-1"/>
<property type="protein sequence ID" value="ENSP00000358983"/>
<property type="gene ID" value="ENSG00000077150"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000428099">
<molecule id="Q00653-4"/>
<property type="protein sequence ID" value="ENSP00000410256"/>
<property type="gene ID" value="ENSG00000077150"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000652277">
<molecule id="Q00653-4"/>
<property type="protein sequence ID" value="ENSP00000498308"/>
<property type="gene ID" value="ENSG00000077150"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000661543">
<molecule id="Q00653-1"/>
<property type="protein sequence ID" value="ENSP00000499294"/>
<property type="gene ID" value="ENSG00000077150"/>
</dbReference>
<dbReference type="GeneID" id="4791"/>
<dbReference type="KEGG" id="hsa:4791"/>
<dbReference type="UCSC" id="uc001kva.4">
<molecule id="Q00653-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4791"/>
<dbReference type="DisGeNET" id="4791"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000077150.17"/>
<dbReference type="GeneCards" id="NFKB2"/>
<dbReference type="HGNC" id="HGNC:7795">
<property type="gene designation" value="NFKB2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000077150">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="NFKB2"/>
<dbReference type="MIM" id="164012">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615577">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q00653"/>
<dbReference type="OpenTargets" id="ENSG00000077150"/>
<dbReference type="Orphanet" id="1572">
<property type="disease" value="Common variable immunodeficiency"/>
</dbReference>
<dbReference type="Orphanet" id="293978">
<property type="disease" value="Deficiency in anterior pituitary function-variable immunodeficiency syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31600"/>
<dbReference type="eggNOG" id="KOG0504">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160968"/>
<dbReference type="HOGENOM" id="CLU_004343_1_1_1"/>
<dbReference type="InParanoid" id="Q00653"/>
<dbReference type="KO" id="K04469"/>
<dbReference type="OMA" id="IPEYDDF"/>
<dbReference type="OrthoDB" id="916931at2759"/>
<dbReference type="PhylomeDB" id="Q00653"/>
<dbReference type="TreeFam" id="TF325632"/>
<dbReference type="PathwayCommons" id="Q00653"/>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134963">
<property type="pathway name" value="DEx/H-box helicases activate type I IFN and inflammatory cytokines production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214841">
<property type="pathway name" value="PKMTs methylate histone lysines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-448706">
<property type="pathway name" value="Interleukin-1 processing"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4755510">
<property type="pathway name" value="SUMOylation of immune response proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603029">
<property type="pathway name" value="IkBA variant leads to EDA-ID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607761">
<property type="pathway name" value="Dectin-1 mediated noncanonical NF-kB signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5676590">
<property type="pathway name" value="NIK--&gt;noncanonical NF-kB signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-844456">
<property type="pathway name" value="The NLRP3 inflammasome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9660826">
<property type="pathway name" value="Purinergic signaling in leishmaniasis infection"/>
</dbReference>
<dbReference type="SIGNOR" id="Q00653"/>
<dbReference type="BioGRID-ORCS" id="4791">
<property type="hits" value="25 hits in 897 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NFKB2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q00653"/>
<dbReference type="GeneWiki" id="NFKB2"/>
<dbReference type="GenomeRNAi" id="4791"/>
<dbReference type="Pharos" id="Q00653">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q00653"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="RNAct" id="Q00653">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000077150">
<property type="expression patterns" value="Expressed in left lobe of thyroid gland and 186 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q00653">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q00653">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0033257">
<property type="term" value="C:Bcl3/NF-kappaB2 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0042025">
<property type="term" value="C:host cell nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002268">
<property type="term" value="P:follicular dendritic cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002467">
<property type="term" value="P:germinal center formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038061">
<property type="term" value="P:NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034097">
<property type="term" value="P:response to cytokine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048511">
<property type="term" value="P:rhythmic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048536">
<property type="term" value="P:spleen development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd01177">
<property type="entry name" value="IPT_NFkappaB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.340">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002110">
<property type="entry name" value="Ankyrin_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR020683">
<property type="entry name" value="Ankyrin_rpt-contain_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036770">
<property type="entry name" value="Ankyrin_rpt-contain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000488">
<property type="entry name" value="Death_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR002909">
<property type="entry name" value="IPT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR033926">
<property type="entry name" value="IPT_NFkappaB"/>
</dbReference>
<dbReference type="InterPro" id="IPR000451">
<property type="entry name" value="NFkB/Dor"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR030492">
<property type="entry name" value="RHD_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR032397">
<property type="entry name" value="RHD_dimer"/>
</dbReference>
<dbReference type="InterPro" id="IPR011539">
<property type="entry name" value="RHD_DNA_bind_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR037059">
<property type="entry name" value="RHD_DNA_bind_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24169">
<property type="entry name" value="PTHR24169"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12796">
<property type="entry name" value="Ank_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00531">
<property type="entry name" value="Death"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16179">
<property type="entry name" value="RHD_dimer"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00554">
<property type="entry name" value="RHD_DNA_bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01415">
<property type="entry name" value="ANKYRIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00057">
<property type="entry name" value="NFKBTNSCPFCT"/>
</dbReference>
<dbReference type="SMART" id="SM00248">
<property type="entry name" value="ANK"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00005">
<property type="entry name" value="DEATH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00429">
<property type="entry name" value="IPT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48403">
<property type="entry name" value="SSF48403"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50297">
<property type="entry name" value="ANK_REP_REGION"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50088">
<property type="entry name" value="ANK_REPEAT"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="PROSITE" id="PS01204">
<property type="entry name" value="REL_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50254">
<property type="entry name" value="REL_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0040">ANK repeat</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Nuclear factor NF-kappa-B p100 subunit" id="PRO_0000030321">
<location>
<begin position="1"/>
<end position="900"/>
</location>
</feature>
<feature type="chain" description="Nuclear factor NF-kappa-B p52 subunit" id="PRO_0000030322">
<location>
<begin position="1"/>
<end position="454"/>
</location>
</feature>
<feature type="domain" description="RHD" evidence="9">
<location>
<begin position="38"/>
<end position="343"/>
</location>
</feature>
<feature type="repeat" description="ANK 1">
<location>
<begin position="487"/>
<end position="519"/>
</location>
</feature>
<feature type="repeat" description="ANK 2">
<location>
<begin position="526"/>
<end position="555"/>
</location>
</feature>
<feature type="repeat" description="ANK 3">
<location>
<begin position="559"/>
<end position="591"/>
</location>
</feature>
<feature type="repeat" description="ANK 4">
<location>
<begin position="599"/>
<end position="628"/>
</location>
</feature>
<feature type="repeat" description="ANK 5">
<location>
<begin position="633"/>
<end position="663"/>
</location>
</feature>
<feature type="repeat" description="ANK 6">
<location>
<begin position="667"/>
<end position="696"/>
</location>
</feature>
<feature type="repeat" description="ANK 7">
<location>
<begin position="729"/>
<end position="758"/>
</location>
</feature>
<feature type="domain" description="Death">
<location>
<begin position="764"/>
<end position="851"/>
</location>
</feature>
<feature type="region of interest" description="GRR">
<location>
<begin position="346"/>
<end position="377"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="8">
<location>
<begin position="337"/>
<end position="341"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich">
<location>
<begin position="350"/>
<end position="400"/>
</location>
</feature>
<feature type="site" description="Cleavage (when cotranslationally processed)">
<location>
<begin position="454"/>
<end position="455"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form NFKB2-IGHA1 oncogene">
<location>
<begin position="490"/>
<end position="491"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="23"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="161"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="429"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="713"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="715"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="717"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="812"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAP3K14" evidence="10">
<location>
<position position="866"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAP3K14" evidence="10">
<location>
<position position="870"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="12">
<location>
<position position="855"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_040082" evidence="24">
<original>GSLGFFPSSLAYSPYQSGAGPMGCYPGGGGGAQMAATVPSRDSGEEAAEPSAPSR</original>
<variation>EGVLMEGGVKVREAVEEKNLGEAGRGLHACNPALWEAKAGRLPEIRSSRPAWPTA</variation>
<location>
<begin position="374"/>
<end position="428"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_040083" evidence="24">
<location>
<begin position="429"/>
<end position="900"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_040084" evidence="22 23 24 25">
<location>
<position position="860"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45581936." id="VAR_022223" evidence="21">
<original>E</original>
<variation>K</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45580031." id="VAR_022224" evidence="21">
<original>G</original>
<variation>R</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11574848." id="VAR_051781">
<original>A</original>
<variation>G</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45471103." id="VAR_022225" evidence="21">
<original>G</original>
<variation>R</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In truncated form EB308." id="VAR_018452">
<location>
<begin position="618"/>
<end position="900"/>
</location>
</feature>
<feature type="sequence variant" description="In truncated form p80HT." id="VAR_006909">
<original>AGN</original>
<variation>SAS</variation>
<location>
<begin position="667"/>
<end position="669"/>
</location>
</feature>
<feature type="sequence variant" description="In truncated form p80HT." id="VAR_006910">
<location>
<begin position="670"/>
<end position="900"/>
</location>
</feature>
<feature type="sequence variant" description="In truncated form LB40." id="VAR_018453">
<location>
<begin position="703"/>
<end position="900"/>
</location>
</feature>
<feature type="sequence variant" description="In CVID10; unknown pathological significance; de novo mutation; dbSNP:rs727502787." id="VAR_074035" evidence="15">
<original>D</original>
<variation>G</variation>
<location>
<position position="865"/>
</location>
</feature>
<feature type="sequence variant" description="In CVID10; unknown pathological significance; de novo mutation; dbSNP:rs727502788." id="VAR_074036" evidence="15">
<original>A</original>
<variation>V</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="mutagenesis site" description="Two-fold reduction in heterodimerization with RelA." evidence="19">
<original>YLL</original>
<variation>AAA</variation>
<location>
<begin position="247"/>
<end position="249"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in cleavage rate or products." evidence="19">
<original>P</original>
<variation>A</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in cleavage rate or products." evidence="19">
<original>G</original>
<variation>A</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in cleavage rate or products." evidence="19">
<original>A</original>
<variation>P</variation>
<location>
<position position="405"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in cleavage rate or products." evidence="19">
<original>Q</original>
<variation>N</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation; when associated with A-715 and A-717." evidence="19">
<original>S</original>
<variation>G</variation>
<location>
<position position="713"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation; when associated with G-713 and A-717." evidence="19">
<original>S</original>
<variation>A</variation>
<location>
<position position="715"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation; when associated with G-713 and A-715." evidence="19">
<original>S</original>
<variation>A</variation>
<location>
<position position="717"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in MAP3K14-induced phosphorylation; no inducible processing occurs; when associated with A-869." evidence="10">
<original>S</original>
<variation>A</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in MAP3K14-induced phosphorylation; no inducible processing occurs; when associated with A-865." evidence="10">
<original>S</original>
<variation>A</variation>
<location>
<position position="870"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB21124." ref="2" evidence="26">
<original>K</original>
<variation>E</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA43715/CAA43716 and 11; AAA68171." ref="1 11" evidence="26">
<original>I</original>
<variation>T</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA43715." ref="1" evidence="26">
<original>G</original>
<variation>R</variation>
<location>
<position position="396"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB21124." ref="2" evidence="26">
<original>EP</original>
<variation>DA</variation>
<location>
<begin position="433"/>
<end position="434"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; AA sequence." ref="12" evidence="26">
<original>R</original>
<variation>K</variation>
<location>
<position position="459"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA43715." ref="1" evidence="26">
<original>G</original>
<variation>C</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA43715 and 2; AAB21124." ref="1 2" evidence="26">
<original>A</original>
<variation>R</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA43715." ref="1" evidence="26">
<original>K</original>
<variation>L</variation>
<location>
<position position="741"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB21124." ref="2" evidence="26">
<original>A</original>
<variation>T</variation>
<location>
<position position="860"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB21124." ref="2" evidence="26">
<original>E</original>
<variation>K</variation>
<location>
<position position="876"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA43715." ref="1" evidence="26">
<original>C</original>
<variation>S</variation>
<location>
<position position="891"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="39"/>
<end position="44"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="48"/>
<end position="51"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="56"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="79"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="87"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="98"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="106"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="116"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="120"/>
<end position="124"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="136"/>
<end position="140"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="146"/>
<end position="158"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="168"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="189"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="205"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="220"/>
<end position="222"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="230"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="236"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="240"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="245"/>
<end position="252"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="255"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="258"/>
<end position="264"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="270"/>
<end position="273"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="286"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="303"/>
<end position="311"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="312"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="321"/>
<end position="326"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="439"/>
<end position="467"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="470"/>
<end position="475"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="476"/>
<end position="480"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="491"/>
<end position="497"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="501"/>
<end position="512"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="513"/>
<end position="515"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="519"/>
<end position="521"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="530"/>
<end position="536"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="540"/>
<end position="548"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="563"/>
<end position="567"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="575"/>
<end position="582"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="586"/>
<end position="588"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="589"/>
<end position="593"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="597"/>
<end position="599"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="603"/>
<end position="609"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="613"/>
<end position="621"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="631"/>
<end position="633"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="637"/>
<end position="643"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="647"/>
<end position="654"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="655"/>
<end position="657"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="671"/>
<end position="678"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="681"/>
<end position="689"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="733"/>
<end position="735"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="740"/>
<end position="751"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="752"/>
<end position="754"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="772"/>
<end position="782"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="783"/>
<end position="786"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="791"/>
<end position="798"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="801"/>
<end position="808"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="813"/>
<end position="823"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="828"/>
<end position="838"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="841"/>
<end position="848"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1A3Q"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2D96"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3DO7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4OT9"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00265"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11239468"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11526476"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14676825"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16477006"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24140114"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25524009"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7925301"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8152812"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8453667"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8887665"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9315679"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1876189"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<sequence length="900" mass="96749" checksum="6BAD7038834783CA" modified="2006-10-17" version="4">MESCYNPGLDGIIEYDDFKLNSSIVEPKEPAPETADGPYLVIVEQPKQRGFRFRYGCEGPSHGGLPGASSEKGRKTYPTVKICNYEGPAKIEVDLVTHSDPPRAHAHSLVGKQCSELGICAVSVGPKDMTAQFNNLGVLHVTKKNMMGTMIQKLQRQRLRSRPQGLTEAEQRELEQEAKELKKVMDLSIVRLRFSAFLRASDGSFSLPLKPVISQPIHDSKSPGASNLKISRMDKTAGSVRGGDEVYLLCDKVQKDDIEVRFYEDDENGWQAFGDFSPTDVHKQYAIVFRTPPYHKMKIERPVTVFLQLKRKRGGDVSDSKQFTYYPLVEDKEEVQRKRRKALPTFSQPFGGGSHMGGGSGGAAGGYGGAGGGGSLGFFPSSLAYSPYQSGAGPMGCYPGGGGGAQMAATVPSRDSGEEAAEPSAPSRTPQCEPQAPEMLQRAREYNARLFGLAQRSARALLDYGVTADARALLAGQRHLLTAQDENGDTPLHLAIIHGQTSVIEQIVYVIHHAQDLGVVNLTNHLHQTPLHLAVITGQTSVVSFLLRVGADPALLDRHGDSAMHLALRAGAGAPELLRALLQSGAPAVPQLLHMPDFEGLYPVHLAVRARSPECLDLLVDSGAEVEATERQGGRTALHLATEMEELGLVTHLVTKLRANVNARTFAGNTPLHLAAGLGYPTLTRLLLKAGADIHAENEEPLCPLPSPPTSDSDSDSEGPEKDTRSSFRGHTPLDLTCSTKVKTLLLNAAQNTMEPPLTPPSPAGPGLSLGDTALQNLEQLLDGPEAQGSWAELAERLGLRSLVDTYRQTTSPSGSLLRSYELAGGDLAGLLEALSDMGLEEGVRLLRGPETRDKLPSTAEVKEDSAYGSQSVEQEAEKLGPPPEPPGGLCHGHPQPQVH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

